IMRX Clase A Immuneering Corporation - Class A Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 5, 2026
$4,07
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$3,86mínimo 52 semanas
$8,48máximo 52 semanas
P/E
-5.2
BPA
$-1.27
Ingresos
$0
tus insignias
Rango 52S
$4–$8
Calificación del Analista
BUY
Precio Objetivo
$17
P/E
-5.2
ROE
-45.3%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IMRX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.07
P/E
-5.2
BPA
$-1.27
Ingresos
$0
ROE
-45.3%
Rango 52S
$4–$8
IMRX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02020-12-31 → 2023-12-31
BPA$-1.272020-12-31 → 2025-12-31
Flujo de caja libre$-45M2021-12-31 → 2025-12-31
Margen neto·2021-12-31 → 2022-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IMRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -5.2promedio 5A ≈-3.9 | ≈-3.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IMRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -39.4%promedio 5A ≈-46.6% | ≈-46.6% | -34.5% | Débil | |
| ROE | -45.3%promedio 5A ≈-57.7% | ≈-57.7% | -38.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IMRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 19.5promedio 5A ≈14.9 | ≈14.9 | 17.6 | En línea | |
| Quick Ratio (Ratio Rápido) | 12.8promedio 5A ≈13.0 | ≈13.0 | 11.6 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | IMRX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
15.9%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-0.27 | $-0.27 | 1.2% |
| 31 de marzo de 2026 | May 15, 2026 | $-0.21 | $-0.26 | 18.3% |
| 31 de diciembre de 2025 | $-0.18 | $-0.32 | 43.7% | |
| 30 de septiembre de 2025 | $-0.38 | $-0.40 | 5.0% | |
| 30 de junio de 2025 | $-0.40 | $-0.42 | 5.5% | |
| 31 de marzo de 2025 | $-0.42 | $-0.54 | 21.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $317.0K | $2M | $2M | |
| Cost of Revenue | · | · | $0 | $158.1K | $1M | $1M | |
| Gross Profit | · | · | $0 | $158.8K | $926.9K | $1M | |
| R&D Expense | $42M | $48M | $42M | $36M | $27M | $15M | |
| SG&A Expense | $17M | $16M | $17M | $16M | $8M | $3M | |
| Operating Expenses | $59M | $64M | $58M | $52M | $35M | $18M | |
| Operating Income | $-59M | $-64M | $-58M | $-52M | $-34M | $-17M | |
| Interest Income | $3M | $3M | $4M | $1M | $169.9K | $42.7K | |
| Other Non-op | $311.7K | $441.5K | $1M | $216.8K | $-127.1K | · | |
| Pretax Income | · | · | · | $-51M | $-34M | $-17M | |
| Income Tax | $0 | · | · | · | $-307.5K | · | |
| Net Income | $-56M | $-61M | $-53M | $-51M | $-34M | $-17M | |
| EPS (Basic) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| EPS (Diluted) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| Shares (Basic) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| Shares (Diluted) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| EBITDA | $-59M | $-64M | $-58M | $-52M | $-34M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $129M | $36M | $59M | $73M | $75M | $37M | |
| Short-term Investments | · | · | · | $33M | $74M | · | |
| Receivables | · | · | $0 | $12.4K | $246.0K | $500.1K | |
| Prepaid Expense | $3M | $3M | $3M | $3M | $3M | $141.0K | |
| Current Assets | $176M | $40M | $89M | $109M | $152M | $38M | |
| PP&E (Net) | $938.5K | $1M | $1M | $1M | $807.2K | $64.4K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $981.4K | $193.1K | |
| Accum. Depreciation | $1M | $1M | $728.3K | $418.3K | $174.2K | $128.8K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | · | |
| Intangibles | $321.1K | $350.4K | $379.7K | $408.9K | $439.0K | · | |
| Other Non-current Assets | $283.6K | $1M | $1M | $743.7K | $102.1K | $14.3K | |
| Total Assets | $232M | $53M | $103M | $122M | $167M | $38M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $1M | $1M | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $699.0K | |
| Current Liabilities | $10M | $8M | $8M | $8M | $6M | $2M | |
| Capital Leases | $3M | $4M | $4M | $4M | $5M | $544.8K | |
| Total Liabilities | $14M | $11M | $12M | $13M | $11M | $3M | |
| Paid-in Capital | $499M | $266M | $254M | $220M | $215M | $3M | |
| Retained Earnings | $-280M | $-224M | $-163M | $-110M | $-59M | $-26M | |
| AOCI | $81.3K | $0 | $-778 | $-30.1K | $-49.0K | · | |
| Stockholders' Equity | $218M | $41M | $91M | $110M | $156M | $-22M | |
| Liabilities + Equity | $232M | $53M | $103M | $122M | $167M | $38M |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $324.5K | $355.8K | $322.8K | · | · | · | |
| Stock-based Comp | $6M | $7M | $6M | $4M | $2M | $1M | |
| Deferred Tax | · | · | · | · | $-307.5K | · | |
| Amort. of Intangibles | $29.3K | $29.3K | $29.3K | $30.1K | · | · | |
| Other Non-cash | $4M | $-820.1K | · | · | · | · | |
| Operating Cash Flow | $-45M | $-55M | $-49M | $-44M | $-31M | $-15M | |
| CapEx | $142.2K | $84.9K | $342.7K | $742.5K | $60.8K | $53.4K | |
| Investing Cash Flow | $-89M | $26M | $7M | $42M | $-76M | $-53.4K | |
| Stock Issued | · | · | $28M | $0 | $120M | · | |
| Net Stock Activity | · | · | $28M | · | $120M | · | |
| Financing Cash Flow | $227M | $5M | $28M | $19.0K | $144M | $38M | |
| Net Change in Cash | $93M | $-23M | $-13M | $-2M | $38M | $23M | |
| Free Cash Flow | $-45M | $-55M | $-49M | $-45M | $-31M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 50.1% | 44.6% | · | |
| Operating Margin | · | · | · | -16325.8% | -1629.2% | · | |
| Net Margin | · | · | · | -15937.3% | -1612.3% | · | |
| Pretax Margin | · | · | · | -15937.3% | -1627.1% | · | |
| EBITDA Margin | · | · | · | -16325.8% | -1629.2% | · | |
| ROA | -39.4% | -78.6% | -47.5% | -34.9% | -32.7% | · | |
| ROE | -45.3% | -123.2% | -55.0% | -43.6% | -21.3% | · | |
| ROIC | · | · | · | · | -21.5% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 | · | |
| Quick Ratio | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 0.0 | 2.5 | 5.6 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | $0.00 | $0.01 | $0.15 | · | |
| Cash Flow / Share | $-1.03 | $-1.83 | $-1.72 | $-1.67 | $-2.27 | · | |
| EPS (TTM) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -84.8% | -10.0% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $38.4K | $38.4K | $0 | $317.0K | $2M | · | |
| Net Income TTM | $-56M | $-61M | $-53M | $-51M | $-34M | · | |
| P/E | -5.2 | -1.1 | -3.9 | -2.5 | -6.6 | · | |
| Earnings Yield | -19.3% | -92.7% | -25.6% | -39.4% | -15.2% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $38.4K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $19.3K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $19.0K | |
| R&D Expense | $14M | $11M | $9M | $11M | $10M | $11M | $15M | $11M | $11M | $11M | $12M | $10M | $9M | $10M | $10M | $9M | |
| SG&A Expense | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $19M | $15M | $14M | $15M | $15M | $15M | $19M | $15M | $15M | $15M | $16M | $14M | $14M | $15M | $14M | $13M | |
| Operating Income | $-19M | $-15M | $-14M | $-15M | $-15M | $-15M | $-19M | $-15M | $-15M | $-15M | $-16M | $-14M | $-14M | $-15M | $-14M | $-13M | |
| Interest Income | $1M | $1M | $2M | $415.8K | $324.0K | $438.5K | $415.2K | $547.1K | $826.1K | $804.9K | $754.1K | $855.5K | $1M | $831.3K | $516.2K | $223.0K | |
| Other Non-op | $647.2K | $513.7K | $311.7K | $0 | $0 | $0 | $91.4K | $129.3K | $7.7K | $213.0K | $464.4K | $475.6K | $150.2K | $244.1K | $223.3K | $120.8K | |
| Net Income | $-17M | $-13M | $-12M | $-15M | $-14M | $-15M | $-18M | $-15M | $-14M | $-14M | $-15M | $-13M | $-12M | $-14M | $-13M | $-13M | |
| EPS (Basic) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| EPS (Diluted) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| Shares (Basic) | 64,697,219 | 64,658,809 | · | 39,670,095 | 35,985,878 | 35,529,652 | · | 29,841,883 | 29,653,355 | 29,370,357 | · | 29,266,309 | 28,647,450 | 26,442,216 | · | 26,394,490 | |
| Shares (Diluted) | 64,697,219 | 64,658,809 | · | 39,670,095 | 35,985,878 | 35,529,652 | · | 29,841,883 | 29,653,355 | 29,370,357 | · | 29,266,309 | 28,647,450 | 26,442,216 | · | 26,394,490 | |
| EBITDA | $-19M | $-15M | · | $-15M | $-15M | $-15M | · | $-15M | $-15M | $-15M | · | $-14M | $-13M | $-15M | · | $-13M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $47M | $129M | $228M | $26M | $36M | $36M | $45M | $60M | $66M | $59M | $68M | $104M | $77M | $73M | $76M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $12.4K | $70.2K | |
| Prepaid Expense | $8M | $5M | $3M | $2M | $1M | $2M | $3M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $158M | $161M | $176M | $229M | $28M | $38M | $40M | $55M | $64M | $74M | $89M | $101M | $112M | $94M | $109M | $120M | |
| PP&E (Net) | $879.9K | $937.0K | $938.5K | $892.6K | $964.1K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $997.0K | $909.0K | $818.5K | $728.3K | $648.0K | $569.7K | $492.9K | $418.3K | $344.6K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $306.5K | $313.8K | $321.1K | $328.5K | $335.8K | $343.1K | $350.4K | $357.7K | $365.0K | $372.4K | $379.7K | $387.0K | $394.3K | $401.6K | $408.9K | $416.3K | |
| Other Non-current Assets | $278.1K | $278.1K | $283.6K | $631.3K | $841.7K | $810.9K | $1M | $1M | $1M | $1M | $1M | $743.7K | $743.7K | $743.7K | $743.7K | $737.3K | |
| Total Assets | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M | |
| Accounts Payable | $3M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Accrued Liabilities | $4M | $3M | $8M | $7M | $5M | $3M | $5M | $5M | $4M | $3M | $5M | $3M | $2M | $2M | $5M | $5M | |
| Current Liabilities | $8M | $5M | $10M | $10M | $7M | $5M | $8M | $7M | $7M | $5M | $8M | $6M | $5M | $6M | $8M | $7M | |
| Capital Leases | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Total Liabilities | $11M | $8M | $14M | $13M | $11M | $9M | $11M | $11M | $11M | $9M | $12M | $10M | $10M | $10M | $13M | $12M | |
| Paid-in Capital | $502M | $500M | $499M | $497M | $283M | $281M | $266M | $264M | $258M | $256M | $254M | $252M | $251M | $221M | $220M | $219M | |
| Retained Earnings | $-311M | $-294M | $-280M | $-269M | $-254M | $-239M | $-224M | $-206M | $-192M | $-178M | $-163M | $-148M | $-136M | $-123M | $-110M | $-97M | |
| AOCI | $-406.2K | $-241.0K | $81.3K | · | · | · | $0 | $7.8K | $0 | $-1.1K | $-778 | $5.6K | $-2.2K | $506 | $-30.1K | $-142.5K | |
| Stockholders' Equity | $191M | $207M | $218M | $228M | $29M | $42M | $41M | $58M | $66M | $79M | $91M | $104M | $115M | $98M | $110M | $122M | |
| Liabilities + Equity | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84.5K | $81.4K | $75.9K | $78.8K | $84.5K | $85.3K | $86.1K | $88.9K | $90.5K | $90.2K | $89.8K | $78.3K | $78.2K | $76.5K | · | $68.1K | |
| Stock-based Comp | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Amort. of Intangibles | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | |
| Other Non-cash | · | $-7M | · | · | · | $-812.0K | · | · | · | $-3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-17M | $-18M | $-10M | $-12M | $-9M | $-14M | $-15M | $-13M | $-12M | $-15M | $-12M | $-12M | $-11M | $-14M | $-12M | $-11M | |
| CapEx | $27.4K | $79.9K | $123.9K | $7.3K | $2.1K | $8.9K | $9.4K | $5.3K | $32.8K | $37.5K | $170.9K | $57.1K | $86.7K | $28.0K | $69.3K | $393.1K | |
| Investing Cash Flow | $10M | $-63M | $-89M | $-7.3K | $-2.1K | $-8.9K | $5M | $-5M | $5M | $21M | $3M | $-24M | $9M | $19M | $8M | $-880.1K | |
| Stock Issued | · | · | · | · | $0 | $14M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $14M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24.6K | $180.8K | $-357.5K | $213M | $-62.0K | $14M | $-41.0K | $4M | $0 | $979.9K | $7.8K | $21.4K | $28M | $239.4K | $-184.7K | $-17.2K | |
| Net Change in Cash | $-6M | $-81M | $-99M | $201M | $-10M | $-279.0K | $-9M | $-15M | $-7M | $7M | $-9M | $-36M | $27M | $5M | $-4M | $-12M | |
| Free Cash Flow | · | $-19M | · | · | · | $-14M | · | · | · | $-16M | · | · | · | $-14M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 49.6% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -33466.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| ROA | -14.3% | -10.1% | · | -9.7% | -24.6% | -21.7% | · | -16.0% | -13.9% | -14.6% | · | -10.2% | -9.1% | -10.5% | · | -8.6% | |
| ROE | -15.7% | -10.8% | · | -10.5% | -30.3% | -25.0% | · | -18.1% | -15.5% | -16.2% | · | -11.2% | -9.8% | -11.2% | · | -9.2% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.5 | 32.4 | · | 24.0 | 3.7 | 7.5 | · | 8.0 | 9.4 | 14.4 | · | 17.9 | 20.4 | 17.1 | · | 16.5 | |
| Quick Ratio | 5.1 | 9.5 | · | 23.8 | 3.5 | 7.0 | · | 6.5 | 8.8 | 12.8 | · | 12.1 | 19.0 | 14.0 | · | 16.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.29 | · | · | · | $-0.40 | · | · | · | $-0.53 | · | · | · | $-0.55 | · | · | |
| EPS (TTM) | $-0.93 | $-1.06 | · | $-1.79 | $-1.90 | $-1.97 | · | $-1.96 | $-1.90 | $-1.86 | · | $-1.86 | $-1.92 | $-1.93 | · | $-0.54 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $455 | $455 | · | $455 | $455 | $455 | · | $455 | $455 | $455 | · | $455 | $38.8K | $133.3K | · | $506.1K | |
| Net Income TTM | $-57M | $-54M | · | $-62M | $-62M | $-62M | · | $-58M | $-56M | $-54M | · | $-52M | $-52M | $-51M | · | $-48M | |
| P/E | -5.4 | -5.0 | · | -3.9 | -1.8 | -0.8 | · | -1.3 | -0.7 | -1.6 | · | -4.1 | -5.3 | -5.0 | · | -26.5 | |
| Earnings Yield | -18.6% | -20.1% | · | -25.6% | -56.4% | -129.6% | · | -78.7% | -148.4% | -64.4% | · | -24.2% | -18.9% | -19.9% | · | -3.8% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | · | · | $0 | $317.0K | $2M |
| Margen Bruto % | · | · | · | 50.1% | 44.6% |
| Margen Operativo % | · | · | · | -16325.8% | -1629.2% |
| Beneficio neto | $-56M | $-61M | $-53M | $-51M | $-34M |
| EPS Diluido | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 |
| Ratio Rápido | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-45M | $-55M | $-49M | $-45M | $-31M |
Propietarios institucionales (13F) 121 declarantes · $183.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
121
Valor en tenencia
$183.1M
Nuevas posiciones
37
Posiciones cerradas
19
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 37 (+8 vs trimestre anterior) | 19 (+2 vs trimestre anterior) | 39 (+9 vs trimestre anterior) | 23 (-2 vs trimestre anterior) | +5.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $48 426 004 | 9 704 610 | 26,45% | Acciones |
| BlackRock, Inc. | $21 826 360 | 4 374 020 | 11,92% | Acciones |
| VANGUARD GROUP INC | $16 899 368 | 2 568 293 | 9,23% | Acciones |
| Sanofi | $13 515 709 | 2 708 559 | 7,38% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $11 409 306 | 2 286 434 | 6,23% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 841 807 | 1 370 750 | 3,74% | Acciones |
| STATE STREET CORP | $4 999 955 | 1 001 995 | 2,73% | Acciones |
| DCF Advisers, LLC | $3 942 100 | 790 000 | 2,15% | Acciones |
| MARSHALL WACE, LLP | $3 652 164 | 731 897 | 2,00% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $3 000 262 | 601 255 | 1,64% | Acciones |
| ALETHEA CAPITAL MANAGEMENT, LLC | $2 359 946 | 472 935 | 1,29% | Acciones |
| Summit Financial, LLC | $2 256 797 | 452 264 | 1,23% | Acciones |
| UBS Group AG | $2 239 796 | 448 857 | 1,22% | Acciones |
| Nuveen, LLC | $2 187 427 | 438 362 | 1,19% | Acciones |
| NORTHERN TRUST CORP | $2 180 590 | 436 992 | 1,19% | Acciones |
| LEVIN CAPITAL STRATEGIES, L.P. | $2 065 860 | 414 000 | 1,13% | Acciones |
| CITADEL ADVISORS LLC | $1 928 191 | 386 411 | 1,05% | Acciones |
| SOUTHPORT MANAGEMENT, L.L.C. | $1 825 957 | 277 501 | 1,00% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 800 212 | 360 764 | 0,98% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 791 834 | 359 085 | 0,98% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $1 648 706 | 330 402 | 0,90% | Acciones |
| Burkehill Global Management, LP | $1 497 000 | 300 000 | 0,82% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 439 216 | 288 420 | 0,79% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 409 675 | 282 500 | 0,77% | Opción de compra |
| MORGAN STANLEY | $1 130 190 | 226 491 | 0,62% | Acciones |
| Occam Crest Management LP | $1 129 309 | 278 498 | 0,62% | Acciones |
| D. E. Shaw & Co., Inc. | $1 016 278 | 203 663 | 0,56% | Acciones |
| JANE STREET GROUP, LLC | $915 665 | 183 500 | 0,50% | Opción de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $837 826 | 167 901 | 0,46% | Acciones |
| Permanent Capital Management, LP | $748 500 | 150 000 | 0,41% | Acciones |
| PVG ASSET MANAGEMENT CORP | $730 790 | 146 451 | 0,40% | Acciones |
| HighTower Advisors, LLC | $715 995 | 143 486 | 0,39% | Acciones |
| Bank of New York Mellon Corp | $658 699 | 132 004 | 0,36% | Acciones |
| Kingsview Wealth Management, LLC | $613 770 | 123 000 | 0,34% | Acciones |
| BANK OF AMERICA CORP /DE/ | $578 066 | 115 845 | 0,32% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $544 409 | 109 100 | 0,30% | Opción de venta |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $539 664 | 108 149 | 0,29% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $527 987 | 105 809 | 0,29% | Acciones |
| GOLDMAN SACHS GROUP INC | $480 138 | 96 220 | 0,26% | Acciones |
| Fisher Asset Management, LLC | $440 781 | 88 333 | 0,24% | Acciones |
| Corient Private Wealth LP | $384 679 | 77 090 | 0,21% | Acciones |
| CITADEL ADVISORS LLC | $366 266 | 73 400 | 0,20% | Opción de compra |
| AMERIPRISE FINANCIAL INC | $356 555 | 71 454 | 0,19% | Acciones |
| CIBC Private Wealth Group LLC | $350 357 | 50 051 | 0,19% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $344 574 | 69 053 | 0,19% | Acciones |
| RHUMBLINE ADVISERS | $328 903 | 65 914 | 0,18% | Acciones |
| ALPS ADVISORS INC | $327 633 | 65 658 | 0,18% | Acciones |
| TD Asset Management Inc | $325 328 | 65 196 | 0,18% | Acciones |
| XTX Topco Ltd | $321 331 | 64 395 | 0,18% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $310 084 | 62 141 | 0,17% | Acciones |
Informantes de la empresa 16 insiders · 10 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Benjamin J. Zeskind | PRESIDENT AND CEO | 23 de junio de 2026 P | 2 315 252 | 1 | 0 | $10 944 |
| Andrew Gengos | Chief Financial Officer | 16 de julio de 2026 A | · | 0 | 0 | $0 |
| Biren Amin | CFO, TREASURER | 12 de mayo de 2022 P | 7 898 | 0 | 0 | $0 |
| Brett Matthew Hall | CHIEF SCIENTIFIC OFFICER | 15 de junio de 2026 P | 382 531 | 2 | 0 | $35 547 |
| Leah R Neufeld | CHIEF PEOPLE OFFICER | 13 de marzo de 2026 A | 29 598 | 1 | 0 | $10 898 |
| Harold Eugene Brakewood | Chief Business Officer | 3 de febrero de 2026 A | 11 050 | 1 | 0 | $24 990 |
| Mallory Morales | SVP Finance, CAO | 3 de febrero de 2026 A | 27 533 | 0 | 0 | $0 |
| Michael Bookman | CHIEF LEGAL OFFICER, SECRETARY | 3 de febrero de 2026 A | 4 870 | 0 | 0 | $0 |
| Igor Matushansky | Chief Medical Officer | 3 de febrero de 2026 A | · | 0 | 0 | $0 |
| Scott Barrett | CHIEF MEDICAL OFFICER | 15 de febrero de 2023 A | 7 563 | 0 | 0 | $0 |
| Peter Feinberg | Consejero | 11 de junio de 2026 A | 135 441 | 2 | 0 | $137 025 |
| Laurie Keating | Consejero | 11 de junio de 2026 A | 14 000 | 0 | 0 | $0 |
| Diana Hausman | Consejero | 11 de junio de 2026 A | 3 000 | 0 | 0 | $0 |
| Thomas J. Schall | Consejero | 11 de junio de 2026 A | 74 530 | 1 | 0 | $101 082 |
| CARPENTER ROBERT J | Consejero | 11 de junio de 2026 A | 1 148 839 | 0 | 0 | $0 |
| Ann E Berman | Consejero | 13 de junio de 2025 A | 67 465 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 12 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,06% | 182 497 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 46 623 SH | 19 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 433 352 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 4 578 SH | 1 de octubre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 307 879 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 389 785 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 25 525 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 612 343 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 623 577 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 583 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 3 598 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 493 615 SH | 11 de septiembre de 2026 | Diario |
IMRX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 13 analistas
COMPRA
Objetivo mediano
$15.50
+280,8%
4 30,8%
Compra fuerte
8 61,5%
Compra
1 7,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
6 analistas · 2026-09-28Objetivo medio $17.17 +321,8%
← Por Debajo de Todos los Objetivos
Precio Actual $4.07
Mín$12.00
Media$17.17
Máx$30.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IMRX | · | -5.2 | · | · | -45.3% | · |
| SABS | · | · | · | · | · | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| TLSI | · | · | · | · | · | · |
| ANIK | $133M | -12.6 | -5.9% | -9.6% | -7.5% | 56.6% |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 5, 2026